Pediatrix Medical Group (PDC) Ownership - Who Owns Pediatrix Medical Group?
Pediatrix Medical Group (PDC) Ownership Overview
- 1.62% Insiders
- 34.34% Mutual Funds
- 4.25% Other Institutional Investors
- 35.88% ETFs
- 23.90% Public Companies and Individual Investors
The ownership structure of Pediatrix Medical Group (DE:PDC) stock is a mix of institutional, retail, and individual investors. Approximately 74.48% of the company’s stock is owned by Institutional Investors, 1.62% is owned by Insiders, and 23.90% is owned by Public Companies and Individual Investors.
The ownership structure of Pediatrix Medical Group (DE:PDC) stock is a mix of institutional, retail, and individual investors. Approximately 74.48% of the company’s stock is owned by Institutional Investors, 1.62% is owned by Insiders, and 23.90% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 13, 2026 | Shirley Weis | $855,665 | |
| Dec 16, 2025 | Mark Ordan | $515,430 | |
| Nov 18, 2025 | Michael Rucker | $240,994 | |
| Nov 09, 2025 | Laura A Linynsky | $216,500 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | €295,224 | |
| Dec 31, 2025 | Royce & Associates Llc | €5,449,059 | |
| Dec 31, 2025 | Brandes Investment Partners Lp | €9,460,219 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 13,714,275 | Institution | 17.55% | 395,725,405 |
| Ishares | 9,172,057 | Institution | 11.74% | 264,659,705 |
| Vanguard | 7,909,790 | Institution | 10.12% | 228,236,990 |
| Vanguard Index Funds | 6,610,992 | Institution | 8.46% | 190,760,174 |
| Dfa | 3,173,036 | Institution | 4.06% | 91,557,954 |
| Victory Portfolios | 2,270,000 | Institution | 2.91% | 65,500,850 |
| Dfa Investment Dimensions Group Inc | 2,172,707 | Institution | 2.78% | 62,693,460 |
| Spdr | 1,728,769 | Institution | 2.21% | 49,883,629 |
| Capitol Series Trust | 1,648,328 | Institution | 2.11% | 47,562,504 |
| Invesco | 1,325,319 | Institution | 1.70% | 38,242,080 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 6,610,992 | Institution | 8.46% | 190,760,174 |
| Victory Portfolios | 2,270,000 | Institution | 2.91% | 65,500,850 |
| Dfa Investment Dimensions Group Inc | 2,172,707 | Institution | 2.78% | 62,693,460 |
| Capitol Series Trust | 1,648,328 | Institution | 2.11% | 47,562,504 |
| Fidelity Salem Street Trust | 1,039,331 | Institution | 1.33% | 29,989,896 |
| Wasatch Funds Trust | 990,740 | Institution | 1.27% | 28,587,803 |
| Vanguard Horizon Funds | 946,670 | Institution | 1.21% | 27,316,163 |
| Fidelity Concord Street Trust | 741,832 | Institution | 0.95% | 21,405,562 |
| Bridge Builder Trust | 682,817 | Institution | 0.87% | 19,702,685 |
| Fidelity Select Portfolios | 670,100 | Institution | 0.86% | 19,335,736 |
FAQ
Who Owns Pediatrix Medical Group (DE:PDC)?
According to the latest TipRanks data, approximately 74.48% of the company's stock is held by institutional investors, 1.62% is held by insiders, and 23.90% is held by public companies and individual investors.
What percentage of Pediatrix Medical Group (DE:PDC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 74.48% of Pediatrix Medical Group (DE:PDC) stock is held by institutional investors: 34.34% by mutual funds, 35.88% by ETFs and 4.25% by other institutional investors.
What percentage of Pediatrix Medical Group (DE:PDC) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.90% of Pediatrix Medical Group (DE:PDC) stock is held by public companies and individual investors.
Who owns the most shares of Pediatrix Medical Group (DE:PDC)?
BlackRock, Inc. owns the most shares of Pediatrix Medical Group (DE:PDC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
